3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
10
Carcinoma, Non-Small-Cell Lung
6
Prostatic Neoplasms
4
Lymphoma, Large B-Cell, Diffuse
4
Leukemia, Myeloid, Acute
4
Triple Negative Breast Neoplasms
3
Stomach Neoplasms
3
Recurrence
3
Ovarian Neoplasms
3
Neoplasm Metastasis
3
Multiple Myeloma
3
Lung Neoplasms
3
Thrombosis
2
Squamous Cell Carcinoma of Head and Neck
2
Small Cell Lung Carcinoma
2
Neoplasms
2
Nasopharyngeal Carcinoma
2
Esophageal Squamous Cell Carcinoma
2
Disease
2
Carcinoma, Transitional Cell
2
Carcinoma, Hepatocellular
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Cancer, Papillary
1
Thrombophilia
1
Thrombocytopenia
1
Thoracic Neoplasms
1
Skin Neoplasms
1
Pituitary Neoplasms
1
Pediatric Solid Tumor, Unspecified, Protocol Specific
1
Interventions
radium Ra 223 dichloride
1
niraparib
1
enzalutamide
1
darolutamide
1
capivasertib
1
cabazitaxel
1
apalutamide
1
abiraterone
1
Solutions
1
Prednisone
1
Injections
1
Docetaxel
1
Carboplatin
1
Abiraterone Acetate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Metastatic Castration-resistant Prostate Cancer (mCRPC)
×
Injections
×
Clear all
NCT03903835
2025-04-09
ProBio
Karolinska Institutet
Phase 3
Recruiting
750 enrolled